WallStreetZenWallStreetZen

NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Meredith CookSR. VP GENERAL COUNSEL SEC.2026-03-13500$72.62
$36.31kSell
Christopher MutzHEAD OF RARE DISEASE2026-03-133,162$71.64
$226.53kSell
Thomas Andrew RowlandSVP HEAD - ESTABLISHED BRANDS2026-03-114,772$74.91
$357.47kSell
Krista DavisSVP CHIEF HR OFFICER2026-03-095,087$74.13
$377.10kSell
Christopher MutzHEAD OF RARE DISEASE2026-03-093,602$74.18
$267.20kSell
Nikhil LalwaniPRESIDENT CEO2026-03-0717,060$74.04
$1.26MSell
Christopher MutzHEAD OF RARE DISEASE2026-03-073,314$74.04
$245.37kSell
Ori GutwergSVP GENERICS2026-03-073,314$74.04
$245.37kSell
Stephen P. CareySVP CFO2026-03-075,150$74.04
$381.31kSell
Krista DavisSVP CHIEF HR OFFICER2026-03-061,485$75.00
$111.38kSell

1 of 11

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP83.56%18,737,728$1.38BInsider
Robert E. Brown Jr.75.66%16,967,490$1.25BInsider
Ross J. Mangano25.83%5,792,084$426.93MInsider
Blackrock Inc11.87%2,661,712$196.19MInstitution
Tracy Marshbanks10.29%2,308,568$170.16MInsider
Vanguard Group Inc5.82%1,305,068$96.20MInstitution
Victor A. Morgenstern4.17%936,014$68.99MInsider
State Street Corp3.24%727,204$53.60MInstitution
Global Alpha Capital Management Ltd2.63%590,135$43.50MInstitution
Muthusamy Shanmugam2.42%542,976$40.02MInsider

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP30.60%69.40%Net SellingNet Selling
PRGO65.13%34.87%Net BuyingNet Buying
BHC49.99%50.01%Net BuyingNet Selling
HROW29.75%70.25%Net SellingNet Selling
PAHC43.23%56.77%Net SellingNet Selling
View Top Pharmaceutical Stocks

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 94.39% institutional shareholders, 214.03% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 83.56% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.44B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.